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What is known on the subject?
 Research findings (Soerensen et al., 2013) indicate the percentage of knowledge 
related errors in medicines management is high, accounting for approximately 75% 
of all errors, with insufficient knowledge levels one of the most significant 
contributors of medication errors. Patients should be able to trust nurses to engage 
therapeutically and actively listen to their needs and concerns, responding using 
skills that are helpful, providing information that is clear, accurate, meaningful and 
free from jargon (Walker, 2014). However, without knowledge of pharmacology, it is 
impossible for nurses to be able to provide adequate advice.
2: What the paper adds to the existing knowledge
 This study has examined an area that had not yet been systematically examined 
previously, which draws together previous research findings on mental health 
nurses’ knowledge of adverse events, including side effects and medication errors, 
related to antipsychotic medication within NHS inpatient settings.
3: What are the implications for practice?
 A recent study (Iversen et al., 2018) has found that almost three-quarters (73%) of 
patients taking antipsychotic medication reported side effects to some degree. This 
high number of people experiencing antipsychotic medication side effects is likely to 
compromise care, especially in situations where nurses have inadequate knowledge 
of side effects and are unable to provide effective advice to patients. 
 The findings from this study allow the mental health nursing profession an 
opportunity to reflect on the best means to increase knowledge and increase patient 
safety awareness and benefits for mental health service users. 
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Antipsychotic medications play a significant role in the treatment and recovery of people 
with several psychiatric disorders. However, research findings indicate mental health nurses 
are insufficiently knowledgeable about antipsychotic medication side effects. 
Aim:
To assess practising mental health nurses’ knowledge of antipsychotic medication side 
effects using a Multiple-Choice Questionnaire (MCQ) across National Health Service (NHS) 
Trusts in England.
Hypothesis:
Knowledge of antipsychotic medication side effects amongst registered mental health 
nurses is related to their academic qualification, clinical banding and length of experience.
Method:
A national survey of registered mental health nurses was carried out using an online 
questionnaire which was disseminated by Research and Development departments.
Results:
504 questionnaires were returned, 245 of which had full data and further analysed. The 
mean score for the sample was 14.4 and only 21 participants attained a mark of >80%. 
Implications for Practice:
Two out of three of our hypotheses (that length of experience and clinical banding are 
directly related to knowledge of antipsychotic medication side effects) were supported. 
Our study found many nurses have a suboptimal working knowledge of antipsychotic 
medication side effects which has the potential to compromise care. Strategies need to be 
put in place to enhance pharmacology knowledge.
Keywords:
Antipsychotic, side effects, mental health, nurse, knowledge
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Drug errors in nursing (including mental health nursing) are common. Previous studies 
suggest many of these errors can be attributed to mental health nurses’ poor knowledge of 
psychopharmacology and more specifically, side effects. Medicines errors can cause patient 
harm and, in some instances, can be fatal. Despite the importance of the subject, to our 
knowledge, our study is the only one we are aware of that has directly assessed mental 
health nurses' knowledge of side effects. Results from our study can potentially influence 
clinical practice from a therapeutic and safety perspective and shape Continuous 
Professional Development for mental health nurses.
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Antipsychotic medications can play a significant role in the treatment and recovery of people 
with mental health disorders and in many respects, they are considered a first line of 
treatment for people suffering from a psychotic illness (Leucht et al., 2012). Patients and their 
carers also place a high importance on the use of antipsychotics (Gray et al., 2005; Mancini et 
al., 2005; Piat et al. 2009) but questions remain about their safety and tolerability when used 
long term. An enduring and troubling feature of these medicines is their potential for causing 
serious adverse effects of a degree that can obscure the very reason for their prescription in 
the first place. For example, evidence suggests that patients taking antipsychotics are three 
times more likely to die suddenly from cardiac arrest or stroke than the general population 
(Salvo et al., 2016). Other potentially fatal side effects include cardiac arrhythmias, weight 
gain, neuroleptic malignancy and the serotonin syndrome. Furthermore, an often-overlooked 
complication of antipsychotic usage is, some of their side effects, like akathisia, often mimic 
underlying mental health symptoms and can be confused with actual symptoms of the illness 
(Mutsatsa et al. 2003). Additionally, there is evidence of polypharmacy globally (Barnes and 
Paton, 2011) and an injudicious use of antipsychotics leading to debilitating emotional, 
cognitive and physical effects on the patient and non-adherence to treatment (Mancini et al., 
2005).
Non-adherence to antipsychotics is apparent in a high proportion of patients (up to 90%) 
which can trigger a myriad of problems for the patient including illness relapse and re-
hospitalisation (Higgins, 2007). In this respect, the use of antipsychotic medicines poses 
important challenges for mental health nurses working in in-patient settings. In these 
settings, nurses are responsible for administering each medication dose to the patient, as well 
as being alert for monitoring potential side effects and their management. Furthermore, it is 
estimated that 40% of a nurse’s clinical time is involved with medicines related issues 
(Armitage and Knapman, 2003) and to compound matters, the repertoire of mental health 
medicines has expanded over the last six decades and shows no signs of abating, thus making 
the decision-making process more complex (Glick and Rush, 2016). Consequently, the ability 
of mental health nurses to manage medicines safely and give appropriate advice to patients 
has been called into question (White, 2004). 
There is consistent evidence suggesting that nurses in general have inadequate working 
knowledge of pharmacology (Page and McKinney, 2007; Jones et al., 2010; Ronnie Meechan 
et al., 2011; Keijsers et al., 2012; Wiernik and Public Policy Committee of the American College 
of Clinical, 2015) and this has frequently resulted in suboptimal care to patients. Moreover, 
nurses have reported to be lacking in confidence when discussing treatment options with 
patients, carers and medical colleague (Bressington et al., 2013). A lack of knowledge about 
these medicines can lead to errors during the management process as demonstrated by a 
relatively recent study that observed administration errors accounted for 75% of all medicines 
related errors (Soerensen et al., 2013) and can result in patient harm. For example, anecdotal 
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evidence suggest that nurses frequently mistake the side effects of neuroleptic malignant 
syndrome or akathisia with psychotic agitation. This can result in the nurse administering 
when necessary antipsychotic medication (PRN) but the solution in this case is to withhold 
administering antipsychotic medication to the patient. In addition to patient harm, medicines 
errors can cause significant financial burden for health-care providers due to remedial 
treatment costs and potential litigation expenses (Latter et al., 2000). Therefore, the 
evaluation of mental health nurses’ knowledge of side effects is a valuable starting point 
towards understanding the problem. 
Although many studies have examined side effect knowledge of mental health nurses, most 
of these studies used surveys that sought student nurses’ views (Page and McKinney, 2007) 
or registered nurses and lecturers’ views about pharmacology education (Latter et al., 2000; 
Skingsley et al., 2006). A significant drawback of self-report approach is nurses often rate their 
knowledge of psychopharmacology as higher than their actual knowledge (Ives et al. 1996; R. 
Meechan et al., 2011). To overcome this shortcoming, this study used a direct objective 
questionnaire, exploring registered mental health nurses’ knowledge of side effects related 
to antipsychotic medication, within NHS inpatient settings. Only one study to our knowledge 
has systematically and directly examined mental health nurse’s knowledge of side effects (De 
Hert et al., 2016). However, De Hert et al. only examined the side effects of clozapine, with 
their study based in Belgium.
Aim
The aim of this study was to directly assess practising mental health nurses’ knowledge of 
antipsychotic medication side effects using a Multiple-Choice Questionnaire (MCQ) across 
different National Health Service (NHS) Trusts in England. Specifically, the study sought to test 
the hypothesis that the knowledge of side effects amongst registered mental health nurses is 
related to their academic qualification, clinical banding and length of experience. 
Method and design: 
This study employed a cross sectional questionnaire survey to examine knowledge of 
antipsychotic medication side effects of registered nurses working in in-patient services in 
the NHS. The questionnaire was developed by the authors based on commonly known side 
effects as stated in the British National Formulary (BNF, 2017) and common antipsychotics 
side effects reported to the National Reporting and Learning system (NRLS) from 2005 to 
2016. The authors filtered the data from the NRLS using the following categories; Mental 
Health Unit/Facility; Inpatient areas; Medication; Patient age range (all available selected); 
Patient age at time of event (all ages selected); Speciality (Adult mental health, child and 
adolescent mental health, forensic mental health, inpatient assessment and treatment, 
mental health rehabilitation and older adult mental health); Medication Process (all 
available selected); Medication error (all available selected); Degree of harm (all available 
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selected); Antipsychotic medications (other psychotropic medications excluded); Route (Oral, 
Intramuscular &’blanks’); Year (2005-2016). 
Analysis of the NRLS data using the (above) filters, indicated errors related to clozapine, 
olanzapine, quetiapine, haloperidol, chlorpromazine and risperidone accounted for 
approximately 60% of all reported incidences. Thus, the survey included MCQs specifically 
related to these antipsychotics. 
It was initially piloted on 10 individuals from the first authors NHS hospital trust and the 
feedback received from participants and interpretation of responses led to a reduction in the 
number of questions asked. The final version had 6 items related to demographic data and a 
further 24 questions in the main body. There were 4 answer options, with one correct answer 
only. Each correct answer awarded a mark of one, with a possible total score of 24 (100%). A 
score of 19 (80%) or more gave participants a pass mark. This threshold of 80% is generally 
accepted as the standard pass mark for pharmacology and has been used in previous studies 
(Ndosi and Newell, 2009). The questionnaire was conducted online and the weblink was 
disseminated by Research and Development departments. All 57 mental health trusts in 
England were invited to participate in the study. The design was deemed appropriate for this 
study as MCQs can test more than one isolated fact recall (McCoubrie and McKnight, 2008). 
They are appropriate for measuring knowledge and comprehension and can be designed to 
measure application and analysis (Kaur et al., 2016). 
Only registered mental health nurses, with a clinical banding of 5 and above, working in 
inpatient settings were eligible for the study. Clinical banding refers to the pay scale used in 
the UK’s NHS to pay employees appropriately, according to their abilities and responsibilities, 
under the Agenda for Change (AfC) Scheme, 2019. There are 9 bands (1-9) but this study only 
included nurses who were a band 5 or above as this is the starting clinical band for qualified 
nurses. 
We defined inpatients as any hospital settings where nursing staff have responsibility for 
patient medications and these settings include acute admission wards, psychiatric intensive 
care units and recovery settings. To estimate an a priori sample size need for the study, a 
method of power estimation where the population under study is known was used 
(Denscombe, 2014). The Department of Health (DH) indicate that there was approximately 
19,000 RMNs working in NHS inpatient mental health wards at the time of the study (Rahman, 
2018). Using this figure and a confidence level of 95%, a sample size of 378 was extrapolated 
from a chart (Krejcie and Morgan, 1970; Denscombe, 2014). 
Procedure 
Ethical approval was obtained from the Health Research Authority (HRA) and the Research 
Ethics Committee based at the academic institution the research was completed in, after 
which recruitment of participants in NHS mental health trusts across England was initiated 
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from September 2017 and ended in Mid-February 2018. To help with the efficient distribution 
of the questionnaire nationwide, Research and Development (R&D) teams of various NHS 
trusts were enlisted to disseminate the survey. In addition, social media sites (specifically 
Twitter and Facebook), were used to promote and maximize exposure of the study.
The data was analysed using SPSS version 24 (IBM, 2018). Initially, descriptive statistics were 
used to explore the demographic characteristics of the sample. Further, multiple regression 
techniques were used to establish relationships between variables and a One-Way Analysis 
of Variance (ANOVA) was used to estimate group differences and subsequent post hoc tests.
Results 
In total 504 questionnaires were returned. Of these, 245 (48.6%) questionnaires were 
returned with full data, 165 (32.7%) respondents only entered demographic data and a 
further 94 (18.7%) clicked the link but did not complete any aspect of the survey. The mean 
score for the sample was 14.4 (60%) with a standard deviation of 3.4. The scores ranged from 
2 (8.3%) to 22 (91.7%) and only 21 (8.6%) out of 245 participants attained a mark of 80% or 
above. 
Respondents’ characteristics 
As shown in Table 1, most of the respondents were White British and females and this is in 
accord with previous research that has examined ethnicity and gender on inpatient 
psychiatric wards (Bowers et al., 2009). The sample age ranged from 21 years to 61 years or 
over, with most nurses being in the 41-50 years age category, accounting for 28.6% of the 
total sample. Just less than half of the respondents, 121 (49.4%), had completed a Bachelor’s 
degree with the second largest group (79) having an associate degree/diploma (32.2%). There 
were only 37 (15.1%) of respondents who had completed a master’s degree and none who 
had completed a PhD. With regards to clinical banding, most of the respondents worked as 
Band 5 (40.0%), band 6 (32.2%), Band 7 (20.8%), Band 8 or above (5.7%). Band 6 nurses 
recorded the lowest pass rate with only 2.5% of participants passing. The group that 
registered the highest rate of passes was the Band 8 or above group with 28.6% of participants 
passing.  When the percentage of those who passed was analysed by level of education 
further, the data revealed that level of educational attainment was not associated with pass 
rates in the survey. See table 2 below for further details. 
Statistical analysis 
The outcome variable of interest (total knowledge scores on the MCQ) was tested for normal 
distribution to justify the use of using statistical tests. The data was explored for skewness 
and kurtosis was tested which was 1.3 and -0.8 respectively, suggesting normal distribution 
(Peat and Barton 2008). For total knowledge scores, the mean scores between the groups 
(clinical banding and educational level) were compared using a one-way ANOVA. For clinical 
banding the results showed there was an in-group difference which was statistically 
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significant (F=4.3, df=3, p=.01). To determine which groups differed, a post hoc Bonferroni 
test was conducted and revealed that Band 8 nurses scored significantly better than Band 5 
nurses. However, this was only at trend level (p=0.08). For level of education, the difference 
in scores were not statistically significant (F= .094, df=2, p=0.91). See table 3 below for further 
details. 
A stepwise linear regression was carried out to determine whether nurses’ knowledge of 
antipsychotic medication side effects was influenced by age or length of service. Only length 
of service appeared to significantly influence knowledge of antipsychotic medication side 
effects but accounting for only 4% of the variance (Adjusted R2 =0.04, df =1, p=0.001). This 
indicates that nurses who have been working for a relatively longer period are more likely to 
have a better knowledge of side effects. To determine if the regression analysis was 
sufficiently powered to minimise the potential of a type 2 error, a confirmatory post hoc 
power analysis as recommended by Soper (2018) was carried out. Using results from the 
regression analysis of an effect size of 0.04, a probability level of 0.05 and a sample size of 
245 revealed that the study is powered at 82%. A sample size powered at 80% or above is 
normally considered to be adequate to avoid a type 2 error (Magnusson, 2018). Hence, our a 
priori sample estimate of a minimum of 378 was in fact an overestimate of the true sample 
size required. 
Discussion
This study sought to examine the hypothesis that knowledge of side effects amongst 
registered mental health nurses is related to their academic qualification, clinical banding, 
and length of experience. The study found that only length of experience and clinical banding 
was related to the level of side effects knowledge. In other words, those who have been 
working as mental health nurses for a longer period were more likely to have a better 
knowledge of antipsychotic medication side effects. Equally, those who were of a higher 
clinical banding were more likely to have a better knowledge of side effects than those of 
lower banding. However, higher clinical banding could simply reflect length of service. 
A key finding from this study is that only 21 (9%) of the nurses who took part passed at the 
80% threshold. This finding supports the view that mental health nurses have a relatively poor 
knowledge of antipsychotic medication side effects and this is in line with previous findings 
by (De Hert et al., 2016) who assessed side effects knowledge of clozapine of 85 mental health 
nurses in Belgium. They found that only 25% of participants passed the test. The difference in 
pass rate between De Hert and colleagues and our study could be explained by the pass 
threshold used. Whilst our study used an 80% pass threshold, De Hert and colleagues used a 
50% pass threshold and focused on clozapine side effects. Furthermore, demographic and 
cultural differences could have accounted for the differences.
From a service user perspective, limited knowledge of side effects has led to treatment 
dissatisfaction according to some investigators. Concerns about nurses’ purported lack of 
recognition and attention to adverse medication effects are prominent topics of discussion 
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for patient self-support groups (Gray et al., 2005). Considering that a recent study found that 
nearly three-quarters (73%) of patients taking antipsychotics reported side effects to some 
degree (Iversen et al., 2018), the findings from this study assume an even greater clinical 
significance. 
This relatively high number of people experiencing antipsychotic medication side effects is 
likely to compromise care, especially in situations where nurses have inadequate knowledge 
of side effects and are unable to provide effective advice to patients. Patients should be able 
to trust nurses to engage therapeutically and actively listen to their needs and concerns, 
responding using skills that are helpful, providing information that is clear, accurate, 
meaningful and free from jargon (Walker, 2014). However, without knowledge of 
pharmacology, it is impossible for nurses to be able to provide adequate advice. This means 
that patients may continue to have knowledge deficits regarding the effects of medicines and 
side effects of the medications they are taking (Pearson et al., 2018). As a result, this is likely 
to result in treatment dissatisfaction which in turn, may lead to treatment non-adherence on 
the part of the patient. Non adherence to treatment due to unpleasant side effects is 
relatively common (Velligan et al., 2017) and almost always leads to patient relapse 
(Dibonaventura et al., 2012).
The suboptimal knowledge of antipsychotic medication side effects is not unique to mental 
health nurses as previous studies have indicated. A study that assessed the confidence of 241 
general practitioners to prescribe for mental health conditions found that 71.5% of the 
general practitioners reported that they prescribe psychotropic medication to their patients 
despite often assessing their own knowledge of these drugs, including side effect knowledge 
as absent or marginal (Fraser and Oyama, 2013). This finding is echoed in an earlier view 
expressed by eminent psychiatrists in the UK who expressed doubts about the adequacy of 
current clinical psychopharmacological training and competence of newly qualified 
psychiatrists. They called for the postgraduate education in psychopharmacology for doctors 
to be substantial and rigorous (Harrison et al., 2011). Overall, findings from our study are 
consistent with previous studies that examined and concluded that antipsychotic medication 
side effects knowledge is inadequate in mental health professionals as whole.  
A further, well-recognized clinical significance of the findings is that inadequate side effect 
knowledge can increase the risk for errors (Lu et al., 2013). This view is supported by a 
systematic review by (Keers et al., 2013), which examined 54 studies and reported 
knowledge based errors to be the most commonly reported acts in medicines management 
within hospital settings. Another systematic review of 20 studies found medication errors to 
be as much as 17.5 per 1000 patient days with adverse drug events ranging from 3.3 to 48.0%. 
Their findings further indicate medication errors and adverse drug events were often 
associated with atypical antipsychotics and associated with patient harm (Alshehri et al., 
2017).
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The Institute of Medicine (2007) has previously identified mental health care as having higher 
medication errors than any other branch of health care with errors potentially leading to 
patient harm. This has important health policy implications considering the Francis Report 
(Francis, 2013) that emphasised patients should be protected from avoidable harm. Patient 
safety is further discussed in the Berwick report (Berwick, 2013) and one of the recommended 
guiding principles for improving patient safety is placing the quality and safety of patient care 
above all other aims for the NHS. 
In addition to quality and safety, medication errors can have economic implications for the 
healthcare system. In the United Kingdom (UK), the Department of Health report states that 
preventable medication errors cost the NHS by as much as £2.5bn a year (Torjesen, 2014). 
This is buttressed by an earlier report from the National Patient Safety Agency (NPSA, 2007) 
that conservatively estimated that preventable harm from medicines may cost the NHS in 
excess of £750 million each year in England. It is therefore apparent that medication errors 
due to inadequate knowledge have important policy ramifications at operational and 
strategic levels. 
The inadequate knowledge of side effects has been attributed to the way nurses are trained 
as previous studies have suggested. In general, these studies have concluded that nurses are 
poorly trained in pharmacology and have recommended changes in curriculum that 
accommodates more pharmacology in view of the growth of nurse prescribing (Simonsen et 
al., 2014; Morrison et al., 2017). Other investigators have specifically called for improvement 
in the teaching of psychopharmacology not only for nurses, but for doctors and pharmacists 
as well. This is because current teaching in this subject appears insufficient for undergraduate 
doctors, nurses and pharmacists (Gardner, 2014). Moreover, the explosion in neuro-scientific 
and psychological understanding of mental disorders have compounded the problem (Glick 
and Rush, 2016). Strategies for teaching psychopharmacology are needed at both pre and 
post registration levels to support the development and demonstration of minimum 
competencies for the psychopharmacology for mental health nurses. This may require 
continual review and updating to meet the rapidly changing demands of the mental health 
workplace. A greater focus on psychopharmacology at both pre and post graduate level would 
benefit patients by improving standards in the judicious use of medication.
Despite these well recognised challenges, it has been argued that nurse training has 
increasingly shifted towards a psychosocial model of care in recent years at the expense of 
biosciences (Skingsley et al., 2006). The amount of time undergraduates nurses spend on 
medicines related aspects of care is disproportionate to the time devoted to pharmacology 
teaching within the clinical area or within academic institutions (Morrison-Griffiths et al., 
2002). 
However, findings from this study also suggest many mental health nurses’ knowledge of side 
effects tends to increase with experience and this is supported by previous findings 
(Perehudoff et al., 2016) but a cautionary stance is warranted when interpreting this finding. 
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No matter how much effort goes into improving experiential learning, it will always be 
hampered by time constraints and competing clinical demands. For example, many mental 
health services have been experiencing problems with recruitment of nurses and this has led 
to an increased use of temporary staff (Addicott et al., 2015). Such an environment is likely to 
compromise experiential learning. In support of this view, the results from our regression 
analysis showed that knowledge gained through experience accounted for only 4% of the 
variance, suggesting that 96% of the learning was through other means. Because of these 
limitations, proposals for improving the teaching of psychopharmacology have been 
discussed (Skingsley et al., 2006; Jones et al., 2010; Gardner, 2014) but the implementation 
of these strategies remains a significant challenge. 
One such challenge is that, although some universities in the UK take a very proactive 
approach to delivering structured pharmacology which includes side effects knowledge (Haw 
et al., 2008), only about 33% of lecturers in UK Universities felt pharmacology should be 
covered in pre-registration curriculum (Bradley et al., 2005). From a mental health 
perspective, this raises important questions as 92% of mental health service users in the UK 
are prescribed psychotropic medicines and nurses play a key role in the management of these 
medicines (Healthcare Commission, 2007). Further, this stance goes against 
recommendations from the Royal College of Psychiatrists and the Royal College of Nursing 
who recommend a greater focus on teaching psychopharmacology and physical health to 
mental health nurses at both pre and post registration level (Gardner, 2014). 
Study limitations 
Our study has several limitations which may impact on the generalisability of our findings. 
First, 259 participants completed demographic details or returned the questionnaire 
unanswered and this represents missing data and its associated problems. Eight examples 
cited in research by Nulty (2008) found most online surveys achieved response rates that 
were much lower than the paper-based ones (on average 23% lower). 
Face-to-face studies usually have high response rates for participants. If a participant is willing 
to show up for a study, it is likely they will stay for the entire study, and the researcher will 
have the ability to collect a full set of data (Rice et al., 2017). The ability of a researcher to 
verbally instruct participants and answer questions during the research process greatly 
increases the participants’ understanding of the task they need to complete. However, this 
interaction becomes much more difficult online, where the researchers and participants 
never meet (Crump et al., 2013). Online participants frequently start a study and then 
abandon it after the first few questions. They often review a study to see if it is interesting, 
and then if it does not seem engaging, they will often abandon it after the instructions 
(Buhrmester et al., 2011). Many researchers have reported that they have trouble getting 
online participants to spend more than 20–30 minutes on a survey before they either quit or 
start responding randomly. This may explain our study finding that 19% clicked the link but 
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did not complete the survey.  As previously observed, this limits a researcher’s ability to 
collect accurate data from a time-consuming survey (Crump et al., 2013). 
Second, only 25 of the 57-mental health trust research and development teams agreed to 
take part in the study. Many organisations may have restrictions or, are even unwilling to 
send out instruments on behalf of researchers to protect their staff from unwanted 
solicitations. This high proportion of non-participating trusts experienced by this study may 
constitute an informative systematic bias. 
Third, questionnaires are deemed to lack validity with no way of telling how truthful a 
respondent is being or how much thought they have put into their responses (Popper, 2005). 
It will also not be possible to tell if a respondent completes the survey themselves or if they 
receive help (Schmidt, 1997), which will surely impact the overall findings. However, the 
overall low scores and not once single respondent answering all questions correctly suggests 
this not to be the case, rather implying this study obtained an accurate measure of the current 
state of knowledge.
Fourth, our use of MCQs invites some speculation about the validity of the information provided 
by participants. For example, there is no way of establishing if a participant completed the 
questionnaire without help and this has the potential to impact on the overall findings. However, 
it is also possible to argue that the scores were not simply ‘gamed’ by participants wishing to 
achieve high scores. The overall low pass rate and a lack of 100% suggest individual scores are 
an accurate and real reflection of participants’ knowledge levels.
Strengths of the study
The statistical power from this study is 0.82 suggesting that the likelihood of avoiding a type 
2 error is high.  Our use of data from NRLS has further increased the construct validity of 
questions because they were informed by real life incidents. Therefore, the overall 
questionnaire possesses depth, exploring knowledge levels using meaningful questions 
(Schmidgall, 2017). Another strength of the study is the direct measurement of knowledge 
using MCQ questionnaire. 
There are several advantages of using MCQs as a method of directly assessing knowledge, 
one being that they allow the testing of a broad range of knowledge in a short space of time 
and are easy to construct. Despite criticism from some quarters (Brookhart, 2015), MCQs are 
being use more due to higher reliability, validity, and ease of scoring (Tarrant and Ware, 2012) 
compared to more traditional true/false format MCQs (McCoubrie and McKnight, 2008). 
Conclusion 
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The level of pharmacology knowledge demonstrated by mental health nurses remains a 
contentious issue. This study and other previous studies found that many nurses have a 
suboptimal working knowledge of antipsychotic medication side effects. Specifically, our 
study found that the level of knowledge tends to improve with length of experience, but the 
effect size is very small.  Furthermore, our hypotheses that academic qualification (and age) 
is directly related to knowledge of side effects were not supported. Poor knowledge of anti-
psychotic medication has the potential to compromise care mental health nurses provide in 
clinical practice. Strategies need to be put in place to enhance pharmacology and specifically 
side effects knowledge of mental health nurses.  
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Demographic data for participants who completed survey
(n = 245)
Gender









 21 – 30
 31 – 40
 41 – 50
 51 – 60











 White - British
 White - Irish 
 Any other White background 
 Mixed - White and Asian 
 Mixed - White and Black Caribbean
 Any other mixed background 
 Asian or Asian British - Bangladeshi 
 Asian or Asian British - Indian 
 Asian or Asian British - Pakistani 
 Any other Asian background 
 Black or Black British - African 
 Black or Black British - Caribbean 
 Any other ethnic background
Total
















Highest level of education
 Associates degree/Diploma 
 Bachelor's degree 










Length of practice (years)
 Less than 1 year
 1 - 2 years 
 3 - 5 years
 6 - 10 years 
 11- 15 years
 15 years and above 
Total
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 Band 5 
 Band 6 
 Band 7 









Table describing demographic data of questionnaire respondents 
Table 2
Breakdown of participants who answered 80% or more of questions correctly
















































Table describing percentage of scores answered correctly on questionnaire 
Table 3







































Range 2 – 22 4 - 20 4 – 21 13 - 20
Mean scores answered correctly on questionnaire based on level of education and clinical banding 
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Appendix 1: Questionnaire completed by respondents
Antipsychotic medication side effects knowledge amongst registered mental health nurses in 
England:  A national survey




D2 What is your age?




 61 years and above 
D3 Which of the following best describes your ethnic origin?
 White - British
 White - Irish 
 Any other White background 
 Mixed - White and Asian 
 Mixed - White and Black African 
 Mixed - White and Black Caribbean
 Any other mixed background 
 Chinese 
 Asian or Asian British - Bangladeshi 
 Asian or Asian British - Indian 
 Asian or Asian British - Pakistani 
 Any other Asian background 
 Black or Black British - African 
 Black or Black British - Caribbean 
 Any other Black background 
 Any other ethnic background 
D4 What is the highest degree or level of education you have completed?
 Associates degree/Diploma 
 Bachelor's degree 
 Master's degree 
 PhD 
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D5 How long have you been working as a registered mental health nurse?
 Less than 1 year
 1 - 2 years 
 3 - 5 years 
 6 - 10 years 
 11 - 15 years
 15 years and above 
D6 What band are you currently working as?
 Band 5 
 Band 6 
 Band 7 
 Band 8 or above 
Q1 A patient suffering from Schizophrenia and treated with first generation antipsychotics for 5 years, 
developed abnormal involuntary movement in limbs and face. The patient has:
 Tardive dyskinesia 
 Muscular dystonia 
 Akathisia 
 Neuroleptic malignant syndrome 
Q2 A patient on antipsychotic medication has developed an irritable urge to move limbs and has inner 






 A neurotic disease 
 Seen in Schizophrenia 
 A side effect of lithium 
 A side effect of antipsychotic drugs 
Q4 Neuroleptic malignant syndrome is characterized by:
 Bradycardia 
 Labile hypertension 
 Hypotonia 
 Hypothermia 
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Q5 A side effect of Chlorpromazine, for which anti cholinergic is used, is:
 Blurred vision 
 Oculogyric crisis
 Hypotension 
 Dry mouth 





Q7 A 45 year old was brought to casualty with abnormal involuntary contraction of the muscles especially of 
the head and neck. A day earlier, she had been prescribed Haloperidol 5mg three times daily by the 
psychiatrist. Which of the following is the most likely symptom she is suffering from?
 Acute psychosis 
 Conversion reaction 
 Acute drug dystonia 
 Cerebrovascular accident 
Q8 Which of the following statements is incorrect?
 In psychiatric practice, drug-induced hyperprolactinaemia is most likely due to secondary antipsychotic 
medications effect
 Although first-generation antipsychotics can cause marked elevation in prolactin levels, not all secondary-
generation antipsychotics have this effect 
 Consideration should be given to other causes of hyperprolactinaemia in patients taking antipsychotics if 
the prolactin levels are above the expected range 
 Aripiprazole has only a dopamine antagonist effect. 
Q9 Prolactin-sparing antipsychotics tend to show lower frequencies of hyperprolactinaemia-associated side 





Q10 Which of the following is the best answer: Erectile failure in a middle-aged man with chronic 
Schizophrenia and diabetes mellitus, undergoing phenothiazine treatment:
 May improve if the patient is switched to Quetiapine 
 Can be caused by peripheral vascular disease 
 May be due to depression 
 Can respond to sildenafil treatment 
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Q11 Which of the following is a complication of prescribing high-dose antipsychotics?
 Prolonged PR interval 
 Peaked t-wave 
 Prolonged QTc interval 
 Shortened QTc interval 
Q12 Neuroleptic malignant syndrome is a potentially fatal side-effect of:
 Fluphenazine only 
 All antipsychotic drugs 
 Clozapine only
 Pimozide only 
Q13 Choose the best answer: Tardive dyskinesia is an extrapyramidal symptom consisting of which one of the 
following? 
 Tremor 
 Abnormal face and body movements 
 Restlessness 
 Rhythmic, involuntary movements of the tongue, face and jaw 





Q15 Choose the best answer: Which of the following statements regarding tardive dyskinesia is true?
 It is the least serious manifestation of extrapyramidal symptoms of antipsychotics 
 It may be irreversible on withdrawing therapy and treatment is usually ineffective 
 It only develops on long-term therapy 
 It occurs very rarely, especially in the elderly 
Q16 Prior to administering any medication, which of the following statements is false:
 You must administer any prescribed medication first and then discuss with an authorised prescriber if 
there are any concerns regarding the patient's condition 
 You must have considered the dosage, method of administration, route and timing 
 You must contact the prescriber or another authorised prescriber without delay where assessment of the 
patient indicates that the medicine is no longer suitable 
 In regards to controlled drugs, the second signatory does not need to be another registered professional 
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Q17 If a patient experiences an adverse reaction, which of the following statements is false?
 You must take any action to remedy harm caused by the reaction 
 You must notify the prescriber 
 It should be recorded in the patient's notes
 You do not need to notify the Yellow Card Scheme immediately





Q19 If a patient has been given the wrong dosage/frequency of medication, which of the following do you not 
need to do?
 Document your actions 
 Inform your line manager/employer 
 Inform the pharmacist 
 Report to the prescriber as soon as possible 





Q21 A less common side effect of Quetiapine is?
 Restless legs syndrome 
 Sexual dysfunction 
 Depression 
 Urinary disorders 
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Q24 Hyperglycaemia, weight gain and sometimes Diabetes is more likely to occur with which one of the 
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